Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | -3.45% | -15.15% | -41.42% |
17/06 | Rallybio Corporation Announces Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Rlybocytopenia | CI |
15/05 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.42% | 5.8Cr | |
+34.01% | 5.11TCr | |
+33.84% | 3.89TCr | |
-8.02% | 3.88TCr | |
-8.98% | 2.67TCr | |
+12.56% | 2.63TCr | |
-19.62% | 1.95TCr | |
+39.18% | 1.36TCr | |
+31.47% | 1.25TCr | |
-3.40% | 1.17TCr |
- Stock Market
- Equities
- RLYB Stock
- News Rallybio Corporation
- JMP Securities Adjusts Price Target on Rallybio to $16 From $26, Maintains Market Outperform Rating